IT1262898B - Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk - Google Patents

Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Info

Publication number
IT1262898B
IT1262898B ITFI920071A ITFI920071A IT1262898B IT 1262898 B IT1262898 B IT 1262898B IT FI920071 A ITFI920071 A IT FI920071A IT FI920071 A ITFI920071 A IT FI920071A IT 1262898 B IT1262898 B IT 1262898B
Authority
IT
Italy
Prior art keywords
vqgeesndk
sequence
peptide represented
recombinant antigens
protein recombinant
Prior art date
Application number
ITFI920071A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITFI920071A priority Critical patent/IT1262898B/it
Publication of ITFI920071A0 publication Critical patent/ITFI920071A0/it
Priority to AU37510/93A priority patent/AU3751093A/en
Priority to JP5516285A priority patent/JPH07507447A/ja
Priority to PCT/EP1993/000685 priority patent/WO1993019185A1/en
Priority to CA002132420A priority patent/CA2132420A1/en
Priority to EP93906579A priority patent/EP0637337A1/en
Publication of ITFI920071A1 publication Critical patent/ITFI920071A1/it
Application granted granted Critical
Publication of IT1262898B publication Critical patent/IT1262898B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Sono descritti antigeni ricombinanti proteici la cui immunogenicità é aumentata mediante fusione con il peptide rappresentato dalla sequenza VQGEESNDK.
ITFI920071A 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk IT1262898B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
AU37510/93A AU3751093A (en) 1992-03-23 1993-03-19 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
JP5516285A JPH07507447A (ja) 1992-03-23 1993-03-22 異種の免疫刺激ドメインをその配列内に含む組換え抗原−ワクチンとしてのその使用
PCT/EP1993/000685 WO1993019185A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
CA002132420A CA2132420A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine
EP93906579A EP0637337A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Publications (3)

Publication Number Publication Date
ITFI920071A0 ITFI920071A0 (it) 1992-03-23
ITFI920071A1 ITFI920071A1 (it) 1993-09-23
IT1262898B true IT1262898B (it) 1996-07-22

Family

ID=11350020

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Country Status (6)

Country Link
EP (1) EP0637337A1 (it)
JP (1) JPH07507447A (it)
AU (1) AU3751093A (it)
CA (1) CA2132420A1 (it)
IT (1) IT1262898B (it)
WO (1) WO1993019185A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6639198A (en) 1997-03-07 1998-09-22 Dsm N.V. Radiation-curable composition having high cure speed
CA3197650A1 (en) * 2020-10-02 2022-04-07 Celsion Corporation Polynucleotide vaccines and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217314B (it) * 1987-02-20 1990-03-22 Sclavo Spa Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
NZ235315A (en) * 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors

Also Published As

Publication number Publication date
EP0637337A1 (en) 1995-02-08
ITFI920071A1 (it) 1993-09-23
WO1993019185A1 (en) 1993-09-30
ITFI920071A0 (it) 1992-03-23
JPH07507447A (ja) 1995-08-24
AU3751093A (en) 1993-10-21
CA2132420A1 (en) 1993-09-24

Similar Documents

Publication Publication Date Title
FI921740L (fi) Hybrid polypeptid
ATA257190A (de) Virales polypeptid
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
FI892135L (fi) Rekombinant antikropp.
DE3786767D1 (de) Neues polypeptid.
DE3778287D1 (de) Peptidische zusammensetzung.
FI892714A0 (fi) Rekombinant-coccidiosisvaccin.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
DK162890D0 (da) Polypeptid
FI910272A7 (fi) Ihmisen yhdistelmä-anti-CD18-vasta-aineita
IT8722593A0 (it) Procedimento per l'iniettofusione di materie artificiali termoplastiche.
DK354389D0 (da) Polypeptid
FI910398L (fi) Rekombinant coccidiosisvaccin -5-7-eimeria-ytantigen.
DE69227898D1 (de) Rekombinante hybride porinepitope
IT1262898B (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
KR950700933A (ko) 사람 면역결핍 바이러스(HIV) 표면 당단백질로부터 유래된 합성 폴리펩타이드(Synthetic polypeptides derived from the HIV envelope glycoprotein)
DE3586765D1 (de) Immunogenische hav-peptide.
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
DE3853743D1 (de) Rekombinanter menschlicher ADF.
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
FR2659411B1 (fr) Joint d'etancheite.
IT219614Z2 (it) Struttura di giunzione particolarmente per l'unione reciproca di componenti di illuminazione e simili
FR2664349B1 (fr) Joint d'etancheite.
DK185590D0 (da) Polypeptid

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970325